Moderna
Commercializes mRNA respiratory vaccines while developing oncology and rare-disease therapies.
$136.53
After-hours close−1.46 (−1.06%)
At close$137.99(−3.35%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 88.44%350.91M sharesInsiders 4.44%17.63M sharesOther 7.12%28.25M shares
Shares outstanding 396.79M · Float 372.35M · 93.8% free float
Institutions13F, as of Jun 30, 2026
859 holders · 350.91M shares · 154 new positions · 404 increased · 251 reduced · 93 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 51.86M | 13.07% | +6.19M | Aug 13, 2026 |
| BlackRock, Inc. | 30.60M | 7.71% | +963.5K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 23.21M | 5.85% | +336.3K | Aug 13, 2026 |
| Capital World Investors | 22.28M | 5.61% | +3.58M | Aug 12, 2026 |
| Baillie Gifford & Co | 18.21M | 4.59% | −1.78M | Aug 6, 2026 |
| State Street Corp | 15.73M | 3.96% | +864.8K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 15.58M | 3.93% | −35.1K | Aug 13, 2026 |
| Geode Capital Management, LLC | 9.71M | 2.45% | +275.2K | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 10.60% | 41.30M | 13G | Feb 6, 2026 ↗ |
| Vanguard Capital Management | 6.53% | 25.93M | 13G | Apr 30, 2026 ↗ |
| Capital World Investors | 5.60% | 22.28M | 13G | Aug 12, 2026 ↗ |
| Baillie Gifford & Co | 5.30% | 20.58M | 13G | Feb 9, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Stephane Bancel | director, officer: Chief Executive Officer | 15.59M | 3.93% | Aug 7, 2026 |
| Stephen Hoge | officer: President | 1.48M | 0.37% | Jul 16, 2026 |
| Paul Sagan | director | 312.0K | 0.08% | Mar 4, 2025 |
| Shannon Thyme Klinger | officer: Chief Legal Officer | 73.6K | 0.02% | Jun 8, 2026 |
| James M. Mock | officer: Chief Financial Officer | 66.4K | 0.02% | Jul 6, 2026 |
| Francois Nader | director | 32.8K | 0.01% | May 4, 2026 |
| Elizabeth G. Nabel | director | 19.3K | 0.00% | May 4, 2026 |
| Sandra Horning | director | 18.6K | 0.00% | May 4, 2026 |
| Abbas Hussain | director | 12.1K | 0.00% | May 4, 2026 |
| David M. Rubenstein | director | 9.6K | 0.00% | May 4, 2026 |
4 ten-percent owners hold 14.03M shares by Form 4, outside the officers-and-directors figure above · 21 people have not refiled in the last 18 months (15.98M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 5, 2026 | Stephane Banceldirector, officer: Chief Executive Officer | Sale · 4 lots | 499,246 | $57.52 | 6,187,791 |
| Jul 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $67.60 | 1,483,848 |
| Jun 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $51.37 | 1,483,848 |
| Jun 4, 2026 | Shannon Thyme Klingerofficer: Chief Legal Officer | Sale | 3,471 | $50.00 | 67,468 |
| May 21, 2026 | Noubar Afeyandirector | Sale | 9,263 | $46.84 | 3,924 |
| May 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $48.40 | 1,477,997 |
| May 1, 2026 | Abbas Hussaindirector | Sale | 5,682 | $46.63 | 12,066 |
| Mar 2, 2026 | Shannon Thyme Klingerofficer: Chief Legal Officer | Sale | 13,885 | $52.29 | 59,689 |
| Feb 23, 2026 | Stephen Hogeofficer: President | Sale | 160,009 | $48.84 | 1,457,427 |
| Dec 11, 2025 | Noubar Afeyandirector | Sale | 23,853 | $29.49 | 3,924 |
CongressHouse and Senate disclosures
Not reported.